| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023116 |
| Receipt No. | R000026629 |
| Official scientific title of the study | Effects of hydrogen water on the body fat-reducing, anti-oxidant and anti-fatigue: a randomized, double blind, placebo-controlled study |
| Date of disclosure of the study information | 2017/12/31 |
| Last modified on | 2017/11/17 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effects of hydrogen water on the body fat-reducing, anti-oxidant and anti-fatigue: a randomized, double blind, placebo-controlled study | |
| Title of the study (Brief title) | Effects of hydrogen water on the body fat-reducing, anti-oxidant and anti-fatigue | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adult | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Investigation of the body fat-reducing, anti-oxidant and anti-fatigue effects of hydrogen water. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | VFA, 8, 12 weeks after investigation |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | hydrogen water 500 mL per day for 12 weeks | |
| Interventions/Control_2 | water 500 mL per day for 12 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Subjects who are age from 20 to 64.
2)BMI<30 kg/m2 3)Subjects who are selected VFA and d-ROMs, BAP |
|||
| Key exclusion criteria | 1) Subjects who have the habit of taking test food.
2) Under losing body weight 3) Subjects who have the habit of taking healthcare products. 4) Patients who have serious disease or subjects who have serious disease history. 5) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination. 6) Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period. 7) Subjects who are participated in other clinical studies. 8) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. 9) Subjects who are judged unfit to enroll in this trial by the investigator. |
|||
| Target sample size | 62 | |||
| Research contact person | |
| Name of lead principal investigator | Hiromi To |
| Organization | Kenkoukazoku Co., Ltd |
| Division name | None |
| Address | 10-2, Hirano-cho, Kagoshima-shi, Kagoshima, 892-0848, JAPAN |
| TEL | 099-223-5211 |
| yasushi.nakasone@kenkoukazoku.co.jp | |
| Public contact | |
| Name of contact person | Yasushi Nakasone |
| Organization | Kenkoukazoku Co., Ltd. |
| Division name | Quality Management Division |
| Address | 10-2, Hirano-cho, Kagoshima-shi, Kagoshima, 892-0848, JAPAN |
| TEL | 099-223-5211 |
| Homepage URL | |
| yasushi.nakasone@kenkoukazoku.co.jp | |
| Sponsor | |
| Institute | TTC Co.,Ltd |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026629 |